article thumbnail

Merck settles with insurers regarding a $1.4 billion claim over NotPetya damages

Security Affairs

known as Merck Sharp & Dohme (MSD) outside the United States and Canada, is an American multinational pharmaceutical company. It is one of the largest pharmaceutical companies globally, engaged in the research, development, manufacturing, and marketing of a wide range of healthcare products. Merck & Co., Merck filed a $1.4

Insurance 108
article thumbnail

Intelligent Search – Strategies to Find What You Need

AIIM

Four Strategies for Better Search. For many organizations, especially those in jargon-intense fields like the Oil and Gas, Pharmaceutical, or Healthcare industries, “speaking the right language” goes well beyond standard search terms. Let’s find out.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Why IDMP compliance requires adaptive data governance

Collibra

Pharmaceutical, biotech and medical devices firms, among others, must comply with a plethora of regulations. This requires every company to perform gap analysis to determine what is required and then update their systems, processes, workflows and data management strategy accordingly to ensure compliance.

article thumbnail

Digital Health Transformation: A Practical Guide for Life Sciences Companies

Data Matters

In 2022, many if not most pharmaceutical, medical device, and other life sciences companies established strategies to innovate digital health technology complementary to their existing strategic focus. The digital transformation of the life sciences industry is still widely unfolding across the marketplace.

article thumbnail

Pharmaceutical Company to Plead Guilty and Settle Drug Marketing Charges

Hunton Privacy

Recently, Aegerion Pharmaceuticals announced that it will enter into several settlements and plead guilty to two misdemeanors in connection with alleged violations of HIPAA, drug marketing regulations and securities laws. The criminal charges stem from the company’s marketing of a cholesterol drug called Juxtapid.

article thumbnail

Optimizing clinical trial site performance: A focus on three AI capabilities

IBM Big Data Hub

Despite advancements in the pharmaceutical industry and biomedical research, delivering drugs to market is still a complex process with tremendous opportunity for improvement. The ability to seize these advantages is one way that pharmaceutical companies may be able to gain sizable competitive edge.

article thumbnail

Driving innovation and growth, Reltio powers into 2024

Reltio

Leadership Promotions Reltio took major steps to accelerate our long-term growth strategy and further intensify our focus on customer-centricity by broadening the responsibilities of a pair of key leadership roles. Reltio now proudly serves all of the Top 10 Pharmaceutical companies in the world.¹ As measured by revenue, as of 2024.